BPG is committed to discovery and dissemination of knowledge
Citation
Xiong JF, He Y, Jiang N, Liu YH, Chen GF, Zhao CQ, Zhang SY, Wu YJ, Xu H. Modulation of the gut-liver axis by oxymatrine alleviates metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2026; 32(16): 116187 [DOI: 10.3748/wjg.v32.i16.116187]
Please LOGIN to submit a new comment.